TRIMU 5
From Wikipedia, the free encyclopedia
This article needs more links to other articles to help integrate it into the encyclopedia. (January 2017) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
L-tyrosyl-N-{[(3-methylbutyl)amino]acetyl}-D-alaninamide
|
|
Other names
(2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-{[2-(3-methylbutylamino)acetyl]amino}-1-oxopropan-2-yl]propanamide
|
|
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
|
|
|
|
Properties | |
C19H30N4O4 | |
Molar mass | 378.466 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
TRIMU 5 is a selective agonist of the mu opioid receptor type 2.[1]
References[edit]
- ^ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943–6. PMID 8029266. doi:10.1016/0091-3057(94)90300-X.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |